The activity of the astrocytic enzyme glutamine synthetase (GS) is decreased in the Alzheimer's disease brain, which may have relevance to mechanisms of chronic excitotoxicity. The molecular perturbation(s) that results in GS inactivation is not known, although oxidative lesioning of the enzyme is one likely cause. To assess structural perturbation induced in GS by metal-catalyzed oxidation, a series of spin-labeling studies were undertaken. Ovine GS was oxidized by exposure to iron/hydrogen peroxide and subsequently labeled with the thiol-specific nitroxide probe MTS [(1-oxyl-2,2,5,5-tetramethyl -pyrroline-3-methyl)methanethiosulfonate]. The reaction of MTS with cysteine residues within GS was monitored in real time by electron paramagnetic resonance spectrometry. Structural perturbation of GS, manifested as decreased thiol accessibility, was inferred from an apparent decrease in the rate constant for the secondorder reaction of MTS with protein thiols. A subsequent spin-labeling study was undertaken to compare the structural integrity of GS purified and isolated from Alzheimer's disease-afflicted brain (AD-GS) with that of GS isolated from nondemented, age-matched control brain (C-GS). The rate constant for reaction of MTS with AD-GS was markedly decreased relative to that for the reaction of spin label with C-GS. The kinetic data were partially corroborated by spectroscopic data obtained from circular dichroism analysis of control and peroxide-treated ovine GS. In an adjunct experiment, the interaction of GS with a synthetic analogue of the Alzheimer's-associated ß-amyloid peptide, known to induce free radical oxidative stress, indicated strong interaction of the enzyme with the peptide as reflected by a decrease in the rate constant for MTS binding to reactive protein thiols.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of poorly understood etiology. Histologically, the disease is characterized by the acdumulation of senile (neuritic) plaques rich in amyloid ß-peptide (Aß) within certain brain regions. Plaque accumulation is accompanied by microglial activation, neuronal degeneration, bulk protein oxidation, and dysfunction in multiple transport (Harris et al., 1995a Mark et al., 1995) and enzyme systems, including bioenergetic systems~e.g., reflected by loss of creatine kinase activity (Burbaeva et al., 1992; Hensley et al., 1995a) and cytochrome oxidase (Nutisya et al., 1994) and the nitrogen-fixing glutamine synthetase (GS) component specifically resident in astrocytes (Hensley et al., 1995a Butterfield et al., 1996a) 1.
GS (glutamate-ammonia ligase; EC 6.3.1.2) is an oxidatively sensitive enzyme whose activity is measured easily, and consequently, it has been utilized often as a resident biomarker of oxidative tissue stress (Miller et al., 1978; Oliver et al., 1990; Smith et al., 1991) . US activity is decreased significantly in brain following stroke (Oliver et al., 1990) or hyperoxia (Howard et al., 1996) , in brains of senescent-accelerated mice , and in the AD brain relative to age-matched control brain (Smith et al., 1991; Hensley et al., 1995a) . Addition of AD-associated Aß to GS markedly reduces the enzymatic activity (Aksenov et al., 1995 , the loss of which is prevented by the free radical scavenger N-tert-butyle~-phenylnitrone (Butterfield et al., I 996a; . There are several reasons to consider that the reported decrease of US activity in the AD brain may reflect a fundamental pathogenic process, rather than merely a symptom of tissue oxidation. US ligates ammonia to glutamate, thereby contributing to astrocyte-mediated clearance of the potentially excitotoxic amino acid from the perisynaptic space. A deficit in US activity, therefore, would be expected to exacerbate excitotoxicity, which has been suggested to occur in the AD brain (Coyle and Puttfarcken, 1993; Volterra et al., 1994; Harris et al., 1995a Harris et al., ,b, 1996 .
Moreover, one line of evidence suggests that US in the AD brain is affected in a manner specific to this pathology and refractory from other neurodegenerative conditions, including parkinsonism and Down's syndrome. Gunnersen and Haley (1992) reported that cerebrospinal fluid from AD patients contains significant levels of photoprobe-binding, nonenzymatically active US, whereas leakage of the enzyme into the cerebrospinal fluid of age-matched controls or patients suffering from non-Alzheimer's type neurological disorders (Parkinson's disease, amyotrophic lateral sclerosis, epilepsy) was not observed. GS released from glia into the extracellular space is potentially available to react with other components of a nascent senile plaque. This possibility is interesting and may be etiologically significant given recent observations that US and certain other proteins may modulate the cytotoxicity of senile plaque-resident Aß (Aksenov et al., 1995 Oda et al., 1995; Aksenova et al.. 1996) . In particular, pretreatment of Aß(l-40) with ovine US has been found both to inhibit peptide fibril formation and to increase the toxicity of the peptide incubate toward cultured hippocampal neurons (Aksenov et al., 1995 , suggesting some molecular interaction between the peptide and the enzyme.
Because US has a high specific activity, can be isolated in relatively high purity from brain, and has a high content of solvent-accessible thiol groups, this enzyme is well suited for biophysical studies using the technique of electron paramagnetic resonance (EPR) spin labeling. Human US is a homooctamer (336,400 Da total mass), containing 88 cysteine residues within the multimer complex (Van den Hoff et al., 1991; Bairoch and Boeckmann, 1992) . Most of these cysteine residues are thought to lie within clefts between the US monomers. These thiol functionalities can be rapidly and selectively derivatized by reaction with the thiosulfonate spin label MTS [(l-oxyl-2,2,5,5-tetramethyl -pyrroline -3-methyl)methanethiosulfonate] (Berliner et al., 1982; Butterfield and Lee, 1994; ButterfIeld et al., l994a; Trad et al., 1995; Bhardwaj et al., 1996; Butterfield, 1996a; Subramaniam et al., 1996) . This reaction can be monitored in real time using EPR. As the paramagnetic MTS binds the large enzyme complex, the spin label becomes partially immobilized and the EPR linewidth increases significantly. Hence, measurement of the MTS nitroxide linewidth provides an index to the kinetics of the cysteine thiosulfonate reaction. If the US complex is perturbed by oxidative lesioning, resident thiols may be either cross-linked and inaccessible to MTS or sterically blocked from reaction with the label. In either case, one would expect the kinetics of the MTS reaction with US to differ as a result of the alteration in the enzyme architecture. This article reports spinlabeling results indicating an apparent decrease in the second-order rate constant of the MTS reaction with US-resident thiols after free radical oxidative stress to the enzyme; a similar decrease in the rate constant was observed for the reaction of MTS with US isolated from AD brain (AD-GS) relative to that from agematched control brain (C-US). In a parallel study, circular dichroism (CD) spectroscopy performed on in vitro oxidized ovine US indicated a pronounced increase in proportionate cr-helical content after oxidation. These findings are interpreted as reflecting a collapse of enzyme structure into a more compact arrangement following oxidation, with a concomitant decrease in accessibility of thiol functionalities. In a related experiment, coincubation of ovine US with synthetic Aß(1-40), shown initially by us Hensley et al., 1994b) and confirmed by others (Tomiyama et al., 1996) to be associated with reactive free radicals, drastically decreased consequent MTS binding to the enzyme. These results augment a previous finding that US can interact with amyloid so as to modulate peptide fibrillogenic and neurotoxic properties (Aksenov et al., 1995 .
MATERIALS AND METHODS

GS: sources and spin-labeling procedures
Human US was purified to homogeneity in the laboratory of Dr. Boyd Haley, University of Kentucky College of Pharmacy. GS was purified both from aged-matched brains of nondemented patients and from patients pathologically identified as AD by the Alzheimer's Disease Research Center at the University of Kentucky. The procedure used was a modification of two earlier reported procedures (Meister, 1985; Yamamoto et al., 1987) , in which the major modification was the elimination of the acetone powder extraction and the acid precipitation steps. This six-step procedure, which will be reported in detail elsewhere (B. Jayaram and B. Haley, manuscript in preparation), involved isolation of a 15-25% saturated ammonium sulfate pellet followed by hydroxyapatite and DEAE-cellulose chromatography. Location of the GS elution fractions was determined by photoaffinity labeling. US from these steps was purified further by affinity chromatography using 2 ',5 '-ADP Sepharose 4B (Yamamoto et al., 1987) and Sephacryl S-200 chromatography. GS from these latter two steps was stored at -70°Cand used in 30-~i.gquantities for HPLC ion-exchange purification using a SynChropak AX300 column developed with a potassium phosphate gradient. Purity of the resulting GS was confirmed by C-8 reverse-phase HPLC and sodium dodecyl FIG. 4 . CD spectra of unoxidized and iron/hydrogen peroxidetreated ovine brain GS. The arrow indicates pronounced alteration of the 208 nM peak upon oxidation. WL, wavelength.
FIG. 2.
Kinetics of MTS reaction with unoxidized or experimentally oxidized CS, as measured by EPR spectroscopy; the mean ±SEM of three independent samples is indicated for each time point. The integrated rate law, F(t), is given by Eq. 1. See text.
ending wavelength, 300 nm; scan speed, 20 nm/mm; accumulations, 4; step resolution, 0.5 nm. Figure 2 illustrates the differences in the kinetics of MTS bonding to oxidized versus unoxidized sheep brain US. The rate constant for MTS bonding is diminished by 60% as a result of the experimental oxidation protocol. The maximal bonding was verified to be equivalent between the two treatments by inspection of the EPR linewidths and amplitudes at t = 24 h (data not shown). The likely explanation for these observations is that oxidation affects US structure so as to make cysteine residues less accessible to the MTS spin label.
RESULTS
The kinetics of MTS bonding to US isolated from a nondemented, aged brain versus US isolated from an AD-afflicted brain were also investigated (Fig. 3) .
FIG. 3.
Kinetics of MTS reaction to form GS isolated from control (nondemented) human or AD-afflicted brain, as measured by EPR spectroscopy. The integrated rate law, F(t), is given in Eq. 1. See text.
The rate constants for reaction of MTS with C-US and AD-US were 1.94 X l0~M 1 min' and 8.42 X l0M 1 min', remarkably similar to the results of Fig.   2 . C-US reacts with MTS to form a covalent bond with a rate constant similar to that of sheep brain US; however, AD-US derivatizes the spin label much more slowly, similar to oxidized sheep brain US. A cautionary note should be made about this human data set. A 24-h time point was not measured for these samples, so 1 was taken to be 36.5% J(the value consistently obtained from several studies of sheep brain US). This approximation would not affect the relative sizes of k, but could conceivably affect the absolute magnitudes of these constants. A possible explanation for the behavior of the two human US sources in these preliminary experiments is that AD-GS is structurally modified in such a way that the cysteine residues are sterically hindered from reaction with MTS. To test the hypothesis that oxidative stress affects US structure and, consequently, alters MTS labeling kinetics, CD spectroscopy was performed on concentrated solutions of oxidized and unoxidized ovine brain US (insufficient amounts of human US were available for CD analysis). As shown in Fig. 4 , treatment of US with iron and hydrogen peroxide resulted in a pronounced structural alteration in the CD spectrum of US with a particularly obvious increase in the CD peak at 208 nm, indicating an increase in the proportionate amount of cr-helical content in the US enzyme. These spectra complement the EPR kinetic data and suggest a dramatic effect of oxidation on enzyme architecture. It has long been recognized that unfolding of structured proteins, i.e., by acid denaturation, is accompanied by a decrease in a-helical and ß-sheet content and a proportionate increase in random coil content, as assessed by CD (Appel and Brown, 1971) . The CD data reported here suggest that oxidation of US may increase, rather than decrease, protein secondary structure. A similar conclusion was reached with the thiol protease papain upon oxidation .
Recently, US has been reported to modify the fibrillogenic and toxicologic properties of Aß (Aksenov et al., 1995 , which is thought to play a pathogenic role in AD dementia (Selkoe, 1996) . In an attempt to address possible molecular interactions between US enzyme and Aß, a separate experiment was performed wherein unoxidized sheep brain US was incubated with .1. Neurochem., Vol. 68, No. 6, 1997 l'reshly prepared synthetic Aß( l-40) (I mg/mi) for 6 h prior to MTS addition. The observed rate constant l'or bonding of MTS to this ß-amyloid-treated enzyme was found to be 1.4 X l0'~M 1 min', or 11% of the control value. In contrast, the nontoxic reverse peptide Aß(40-1), when incubated with US, yielded an enzyme whose reaction with MTS was nearly identical to that of control US, i.e., this nontoxic peptide did not modify MTS reactivity with US [second-order rate constants of the reaction of MTS with US previously incubated with buffer: 1.9 X 10~M1 mïnt, with Aß(40-l): 1.6 X i0'~M'' min'I. Similarly, nontoxic reverse sequence peptides did not affect US enzymatic activity . Thus, the presence of toxic amyloid peptide, known to be associated with free radical oxidative stress (Butterfield et al., 1994b, l996a; Hensley et al., 1994b Mark et al., 1995; Butterfield, l996b; Tomiyama et al., 1996) , greatly decreases the facility with which MTS may react with US, consistent with the occurrence of some molecular interaction between enzyme and peptide that precludes spin-label access to protein thiols. It is reported elsewhere (M. Aksenov et al., submitted) that Aß(l-40) interacts with US to produce CD spectra reminiscent of Fig. 4 and increased carbonyl content in US, a hallmark of protein oxidation. In the present investigation, similar CD studies of the interaction of nontoxic showed no altered CD spectrum (data not shown), consistent with the notion of specific interaction of toxic Aß( l-40) and its associated free radicals with US and consistent with the loss of activity of GS activity in AD brain (Hensley et al., 1995a) .
DISCUSSION
In this study, US has been used as a model enzyme for the study of oxidatively induced structural alterations. The technique employed for this study is a novel variation of the EPR spin-labeling methodology. The high sensitivity of the EPR technique allows enzyme structural perturbation to be ascertained in dilute solutions of protein, in physiologically relevant solvents. The data presented are consistent with a model of protein structural collapse about cysteines consequent to oxidation, such that target cysteine residues are less accessible to the thiosulfonate spin label. CD experiments performed in concert with the EPR studies also suggest that US undergoes a defined structural change, rather than a general unfolding, after metalcatalyzed oxidation. US obtained from the brain of an AD-afflicted subject exhibited reduced spin-labeling kinetics relative to US taken from the brain of a control, nondemented individual of similar age. The kinetics of the spin-label reaction in the AD-US preparation suggested enzyme structural compromise similar to that seen in an experimental hydroxyl free radical oxidative stress treatment.
Previous protein spin-labeling data obtained from in vitro oxidized thiol proteases (Subramaniam et al., l996) and in vitro oxidized synaptosomal and erythrocyte membranes (Hensley et al., 1994a; Trad and Butterfield, 1994; Bellary et al., 1995; Butterfield et ai., I 996b ) have also indicated a rigidification, or compaction, of protein structure upon oxidation. These studies examined the segmental motion of protein-bound spin labels, rather than the kinetics of bonding. In these experiments, oxidant stress induced by the hydroxyl radical (Hensley et al., l994a) , menadione (Trad and Butterfield, 1994) , sepsis-related lipopolysaccharide (Bellary et al., 1995) , or Aß free radicals (Butterfield et al., 1996b) were reported to produce EPR-detectable effects in membrane protein preparations similar to that caused by known protein cross-linking agents (Butterfield, 1990) . In addition to these in vitro paradigms for protein oxidation, protocols thought to induce oxidant stress in vivo have been shown to decrease the segmental motion of protein-specific maleimide spin labels derivatized to isolated synaptosomal membrane protein thiols. Protein-specific spin labels bound to synaptosomal membranes isolated from mammalian brain following ischemia/reperfusion injury (Hall et al., 1995a (Hall et al., ,b,c, 1997 , from prolonged ambient hyperoxia (Hensley et al., 1995b; Howard et al., 1996) , in accelerated senescence (Butterfield et al., 1997) , or from rat brain following cortical x-irradiation (Yamaoka et al., 1994) exhibit decreased segmental motion relative to corresponding control tissue. Likewise, synaptosomal membranes obtained from AD-afflicted individuals demonstrate a pronounced protein rigidification that correlates in a brain-regional manner with increased protein carbonyi content and with disease histopathology (Hensley et al., 1995a) . The data in this work and in previous literature are remarkably consistent across experimental models and do not suggest a generalized unfolding of oxidized protein; such unfolding would be expected to increase solvent accessibility of target amino acid residues and increase mobility of the bound spin label (Butterfield, 1982) , which is not observed here. Thus, a collapse of protein architecture into a more compact state consequent to oxidative lesioning might be a common and biochemically relevant motif.
The AD Aß( I-40) peptide, known to be associated with free radical oxidative stress (for reviews, see Butterfield, l996b, 1997; Butterfield et al., 1996a; , when interacted with US caused a marked reduction in MTS reaction kinetics. In contrast, the nontoxic reverse sequence peptide Aß(40-1) did not affect significantly the kinetics of reaction of MTS with US. Prior to the presently reported experiments, no attempt had been made to link the reported diminution of US activity in AD brain (Smith et al., 1991; Hensley et al., 1995a) with an explicit structural parameter indicative of protein structural modification. The diminished kinetics rate of reaction with AD-US complements previous data (Smith et al., 1991; Uunnersen and Haley, 1992; Aksenov et al., 1995 Hensley et al., 1995a ) regarding a perturbation of the US system within the AD brain. A confluence of several oxidative-sensitive glutamate chemistries may be operative in AD: US activity is inhibited by Aß in solution (Hensley et al., l994b ) and the activity is low in AD brain (Smith et al., 1991; Hensley et al., 1995a);  Aß blocks uptake of glutamate by inhibiting the Na + -dependent glutamate transporter (Harris et al., 1995a , thereby potentially making excitotoxic glutamate available to neuronal NMDA receptors; and US interacts with Aß to increase the peptide's toxicity and prevent its fibrillogenesis . Loss of US activity and increased carbonyl content in the enzyme upon Aß interaction can be prevented by free radical scavengers (Butterfield et al., l996a; M. Aksenov et al., submitted) . Aß-associated free radical oxidative stress inhibits US activity, alters the structure of the enzyme, and affects the properties of Aß. This synergy may be of importance in neurotoxicity in AD brain.
